<P>In multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic confidence and for monitoring the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy of cMRI to the most disabling aspects of the
Neurodegeneration in Multiple Sclerosis
β Scribed by E. Capello, A. Uccelli, M. Pizzorno, G.L. Mancardi (auth.), Massimo Filippi, Marco Rovaris, Giancarlo Comi (eds.)
- Publisher
- Springer-Verlag Mailand
- Year
- 2007
- Tongue
- English
- Leaves
- 233
- Series
- Topics in Neuroscience
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
In multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy as to the most disabling aspects of the MS pathology, known to occur in and outside macroscopic lesions. Modern quantitative MR techniques have the potential to overcome the limitations of cMRI, and their application is dramatically changing our understanding of how MS causes irreversible disability. Written by world-renowned scientists, the volume is indispensable for anybody working in this field.
β¦ Table of Contents
Front Matter....Pages I-XI
Front Matter....Pages 1-1
Neuropathological Advances in Multiple Sclerosis....Pages 3-9
Neurophysiology....Pages 11-20
Front Matter....Pages 21-21
Atrophy....Pages 23-35
T1 Black Holes and Gray Matter Damage....Pages 37-45
Magnetization Transfer Imaging....Pages 47-53
Perfusion MR I....Pages 55-64
Diffusion-Weighted Imaging....Pages 65-74
Proton MR Spectroscopy....Pages 75-83
Functional MRI....Pages 85-104
Front Matter....Pages 105-105
Validation of MRI Surrogates....Pages 107-112
Defining Responders and Non-responders....Pages 113-125
Predictive Models in Multimodal Imaging....Pages 127-149
Front Matter....Pages 151-151
Alzheimerβs Disease....Pages 153-161
Other Neurodegenerative Conditions....Pages 163-181
Incorporation of Other Biomarkers....Pages 183-207
Front Matter....Pages 209-209
Critical Review of Existing Trials....Pages 211-220
Design for the Next Trials of Neurodegeneration....Pages 221-232
Back Matter....Pages 233-236
β¦ Subjects
Neurology; Neurosciences; Imaging / Radiology; Neuroradiology; Nuclear Medicine
π SIMILAR VOLUMES
This practical guide for physicians and other health care professionals discusses the impact of fatigue on the individual with MS, the potential etiologies underlying MS-related fatigue, its work up and diagnosis, and pharmacologic and nonpharmacologic management strategies. <P>Fatigue is perhap
Managing multiple sclerosis, with all the associated problems of a progressive chronic disease, requires special knowledge on the part of the clinician. From which drugs to prescribe for an acute attack, to the use of new drugs available to help control the disease process, to managing the myriad of
<p><p>This book provides comprehensive and up-to-date information on the neuropsychiatric disturbances that may be experienced by patients with multiple sclerosis. The first section is designed primarily to describe the general clinical aspects of multiple sclerosis, from epidemiology to assessment
<p>At the annual meetings of the International Federation of Multiple Sclerosis SocieΒ ties (IFMSS) the representatives of the national MS societies of numerous countries assemble for discussions and reports on work accomplished, under way, and to be undertaken in the future. In addition to publicit